In the last week, the Pharma industry is up 8.3%, with AstraZeneca up 9.9%. During this same period, the Indivior underperformed, falling 7.5%. This takes the industry's 12 month performance to a gain of 4.9%. Looking forward, earnings are forecast to grow by 15% annually.
Has the U.K. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 27 Apr 2024 | UK£261.0b | UK£71.7b | UK£10.1b | 32.2x | 26x | 3.6x |
Mon, 25 Mar 2024 | UK£240.9b | UK£70.9b | UK£9.8b | 31.3x | 24.7x | 3.4x |
Wed, 21 Feb 2024 | UK£233.4b | UK£69.7b | UK£9.6b | 35.7x | 24.3x | 3.3x |
Fri, 19 Jan 2024 | UK£236.6b | UK£68.9b | UK£10.7b | 35.9x | 22.2x | 3.4x |
Sun, 17 Dec 2023 | UK£227.4b | UK£69.0b | UK£10.7b | 33.9x | 21.3x | 3.3x |
Tue, 14 Nov 2023 | UK£227.5b | UK£70.3b | UK£10.8b | 53.3x | 21x | 3.2x |
Thu, 12 Oct 2023 | UK£245.7b | UK£70.2b | UK£10.4b | 73.9x | 23.7x | 3.5x |
Sat, 09 Sep 2023 | UK£241.0b | UK£69.7b | UK£10.3b | 53.5x | 23.5x | 3.5x |
Mon, 07 Aug 2023 | UK£238.4b | UK£68.9b | UK£10.2b | 52.8x | 23.5x | 3.5x |
Wed, 05 Jul 2023 | UK£233.5b | UK£67.7b | UK£7.9b | 55.1x | 29.7x | 3.4x |
Fri, 02 Jun 2023 | UK£248.1b | UK£68.3b | UK£7.9b | 55.5x | 31.2x | 3.6x |
Sun, 30 Apr 2023 | UK£254.1b | UK£68.2b | UK£7.9b | 55.7x | 32x | 3.7x |
Tue, 28 Mar 2023 | UK£243.3b | UK£69.7b | UK£6.9b | 55.1x | 35.3x | 3.5x |
Thu, 23 Feb 2023 | UK£250.8b | UK£70.4b | UK£7.2b | 55.5x | 34.9x | 3.6x |
Sat, 21 Jan 2023 | UK£243.8b | UK£79.1b | UK£6.3b | 38.6x | 38.7x | 3.1x |
Mon, 19 Dec 2022 | UK£242.8b | UK£79.8b | UK£6.3b | 37.8x | 38.4x | 3x |
Wed, 16 Nov 2022 | UK£233.8b | UK£80.8b | UK£6.4b | 26.2x | 36.7x | 2.9x |
Fri, 14 Oct 2022 | UK£358.6b | UK£80.6b | UK£3.7b | 19.7x | 97.9x | 4.4x |
Sun, 11 Sep 2022 | UK£229.3b | UK£79.6b | UK£3.7b | 15.5x | 62.1x | 2.9x |
Tue, 09 Aug 2022 | UK£246.3b | UK£77.8b | UK£3.8b | 15.9x | 65.5x | 3.2x |
Thu, 07 Jul 2022 | UK£274.2b | UK£75.5b | UK£4.5b | 16.5x | 60.4x | 3.6x |
Sat, 04 Jun 2022 | UK£261.2b | UK£73.7b | UK£4.6b | 17.2x | 57.1x | 3.5x |
Mon, 02 May 2022 | UK£270.3b | UK£73.6b | UK£4.6b | 17.7x | 59x | 3.7x |
Wed, 30 Mar 2022 | UK£254.1b | UK£66.5b | UK£4.8b | 39.9x | 53x | 3.8x |
Fri, 25 Feb 2022 | UK£91.9b | UK£37.9b | UK£4.7b | 25.2x | 19.5x | 2.4x |
Sun, 23 Jan 2022 | UK£235.4b | UK£61.3b | UK£5.6b | 33x | 41.8x | 3.8x |
Tue, 21 Dec 2021 | UK£230.4b | UK£61.9b | UK£5.7b | 31.3x | 40.7x | 3.7x |
Thu, 18 Nov 2021 | UK£231.7b | UK£61.6b | UK£5.8b | 24.7x | 40.2x | 3.8x |
Sat, 16 Oct 2021 | UK£226.8b | UK£58.2b | UK£7.5b | 27.4x | 30.3x | 3.9x |
Mon, 13 Sep 2021 | UK£217.5b | UK£58.1b | UK£7.5b | 31.5x | 29x | 3.7x |
Wed, 11 Aug 2021 | UK£221.5b | UK£58.1b | UK£7.5b | 27x | 29.5x | 3.8x |
Sun, 06 Jun 2021 | UK£190.4b | UK£56.2b | UK£8.5b | 26.8x | 22.4x | 3.4x |
21.8x
How does U.K. Pharma compare with similar industries?
GB Market | 2.25% | |
Healthcare | 7.50% | |
Pharma | 8.29% | |
Pharma | 8.29% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
AZN AstraZeneca | UK£119.88 | 9.5% +UK£16.2b | 2.1% | PE36.7x | |
GSK GSK | UK£16.53 | 3.4% +UK£2.2b | 14.7% | PE13.7x | |
HIK Hikma Pharmaceuticals | UK£19.13 | 6.3% +UK£252.9m | 3.9% | PE27.9x | |
HCM HUTCHMED (China) | UK£2.90 | 7.4% +UK£170.7m | 15.3% | PE30.7x | |
AGY Allergy Therapeutics | UK£0.029 | 7.5% +UK£9.5m | n/a | PS2.6x |